The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
Open accessAbstract
Many cancer therapies produce toxic side effects whose molecular mechanisms await full elucidation. The most feared and studied side effect of chemotherapeutic drugs is cardiotoxicity. Also, skeletal muscle physiology impairment has been recorded after many chemotherapeutical treatments. However, only doxorubicin has been extensively studied for its side effects on skeletal muscle. Chemotherapeutic‐induced adverse side effects are, in many cases, mediated by mitochondrial damage. In particular, trastuzumab and sunitinib toxicity is mainly associated with mitochondria impairment and is mostly reversible. Vice versa, doxorubicin‐induced toxicity not only includes mitochondria damage but can also lead to a more robust and extensive cell injury which is often irreversible and lethal. Drugs interfering with mitochondrial functionality determine the depletion of ATP reservoirs and lead to subsequent reversible contractile dysfunction. Mitochondrial damage includes the impairment of the respiratory chain and the loss of mitochondrial membrane potential with subsequent disruption of cellular energetic. In a context of increased stress, AMPK has a key role in maintaining energy homeostasis, and inhibition of the AMPK pathway is one of the proposed mechanisms possibly mediating mitochondrial toxicity due to chemotherapeutics. Therapies targeting and protecting cell metabolism and energy management might be useful tools in protecting muscular tissues against the toxicity induced by chemotherapeutic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“Indeed, several clinical studies showed that, by disrupting this cardioprotective mechanism mediated by the ErbB2, trastuzumab exacerbates anthracycline-induced cardiac damage provoking an extremely high incidence of symptomatic heart failure [103].”
BackgroundHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
Powers, S. K., & Jackson, M. J. (2008) · Physiological Reviews · doi:10.1152/physrev.00031.2007 · Cited by 2,459
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Oxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,414
Tyrosine Kinases as Targets for Cancer Therapy
Krause, D. S., & Van Etten, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044389 · Cited by 1,387
The sites and topology of mitochondrial superoxide production
Brand, M. D. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.003 · Cited by 1,217
Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects
Larsen, S., Nielsen, J., Hansen, C. N., Nielsen, L. B., Wibrand, F., Stride, N., Schroder, H. D., Boushel, R., Helge, J. W., Dela, F., et al. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.230185 · Cited by 1,180 · cited 1×
“Due to the high metabolic expense of the skeletal muscle, the number of mitochondria is extremely high in this tissue, although lower than in cardiomyocytes [9].”
BackgroundCardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., Woulfe, K., Pravda, E., Cassiola, F., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,083
ErbB2 is essential in the prevention of dilated cardiomyopathy
Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-459 · Cited by 903
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
Force, T., Krause, D. S., & Van Etten, R. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2106 · Cited by 801
Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
Du, J., Wang, X., Miereles, C., Bailey, J. L., Debigare, R., Zheng, B., Price, S. R., & Mitch, W. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18330 · Cited by 731
Drug-induced oxidative stress and toxicity
Deavall, D. G., Martin, E. A., Horner, J. M., & Roberts, R. (2012) · Journal of Toxicology · doi:10.1155/2012/645460 · Cited by 689
Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity
Ewer, M. S., & Lippman, S. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.827 · Cited by 646
Interaction of reactive oxygen species with ion transport mechanisms
Kourie, J. I. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.1.c1 · Cited by 643
Davies, K. J., & Doroshow, J. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35746-0 · Cited by 631
Alkylating DNA damage stimulates a regulated form of necrotic cell death
Zong, W.-X., Ditsworth, D., Bauer, D. E., Wang, Z.-Q., & Thompson, C. B. (2004) · Genes & Development · doi:10.1101/gad.1199904 · Cited by 618
Trastuzumab containing regimens for early breast cancer
Moja, L., Tagliabue, L., Balduzzi, S., Parmelli, E., Pistotti, V., Guarneri, V., & D'Amico, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006243.pub2 · Cited by 604
Bowles, E. J. A., Wellman, R., Feigelson, H. S., Onitilo, A. A., Freedman, A. N., Delate, T., Allen, L. A., Nekhlyudov, L., Goddard, K. A. B., Davis, R. L., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs317 · Cited by 566
Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity
Keizer, H. G., Pinedo, H. M., Schuurhuis, G. J., & Joenje, H. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90088-j · Cited by 517
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
Özcelik, C., Erdmann, B., Pilz, B., Wettschureck, N., Britsch, S., Hübner, N., Chien, K. R., Birchmeier, C., & Garratt, A. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122249299 · Cited by 473
Yen, H. C., Oberley, T. D., Vichitbandha, S., Ho, Y. S., & St Clair, D. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118909 · Cited by 459
Eschenhagen, T., Force, T., Ewer, M. S., de Keulenaer, G. W., Suter, T. M., Anker, S. D., Avkiran, M., de Azambuja, E., Balligand, J.-L., Brutsaert, D. L., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq213 · Cited by 413
Dobs, A. S., Boccia, R. V., Croot, C. C., Gabrail, N. Y., Dalton, J. T., Hancock, M. L., Johnston, M. A., & Steiner, M. S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70055-x · Cited by 391
Collateral Damage in Cancer Chemotherapy: Oxidative Stress in Nontargeted Tissues
Chen, Y., Jungsuwadee, P., Vore, M., Butterfield, D. A., & St. Clair, D. K. (2007) · Molecular Interventions · doi:10.1124/mi.7.3.6 · Cited by 387
Viani, G. A., Afonso, S. L., Stefano, E. J., De Fendi, L. I., & Soares, F. V. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-153 · Cited by 381
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
Ewer, M. S., & Ewer, S. M. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.121 · Cited by 373
Mechanisms of disuse muscle atrophy: role of oxidative stress
Powers, S. K., Kavazis, A. N., & DeRuisseau, K. C. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00469.2004 · Cited by 368
AMP-Activated Protein Kinase in the Heart: Role During Health and Disease
Arad, M., Seidman, C. E., & Seidman, J. G. (2007) · Circulation Research · doi:10.1161/01.res.0000258446.23525.37 · Cited by 362
Guarneri, V., Lenihan, D. J., Valero, V., Durand, J.-B., Broglio, K., Hess, K. R., Michaud, L. B., Gonzalez-Angulo, A. M., Hortobagyi, G. N., & Esteva, F. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.9551 · Cited by 361
Terai, K., Hiramoto, Y., Masaki, M., Sugiyama, S., Kuroda, T., Hori, M., Kawase, I., & Hirota, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9554-9575.2005 · Cited by 352
New insights into doxorubicin-induced cardiotoxicity: The critical role of cellular energetics
Tokarska-Schlattner, M., Zaugg, M., Zuppinger, C., Wallimann, T., & Schlattner, U. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.06.009 · Cited by 350
Cappetta, D., De Angelis, A., Sapio, L., Prezioso, L., Illiano, M., Quaini, F., Rossi, F., Berrino, L., Naviglio, S., & Urbanek, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1521020 · Cited by 350
Self-citationŠtěrba, M., Popelová, O., Vávrová, A., Jirkovský, E., Kovaříková, P., Geršl, V., & Šimůnek, T. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4795 · Cited by 329
Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress
Gilliam, L. A. A., & St. Clair, D. K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3965 · Cited by 324
Clinical Cardiac Tolerability of Trastuzumab
Perez, E. A., & Rodeheffer, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.120 · Cited by 280
Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions
Stanley, W. C., & Chandler, M. P. (2002) · Heart Failure Reviews · doi:10.1023/a:1015320423577 · Cited by 271
Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
Sawyer, D. B., Peng, X., Chen, B., Pentassuglia, L., & Lim, C. C. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.06.007 · Cited by 270
Zhao, Y. H., Zhou, M., Liu, H., Ding, Y., Khong, H. T., Yu, D., Fodstad, O., & Tan, M. (2009) · Oncogene · doi:10.1038/onc.2009.229 · Cited by 269
Syrjala, K. L., Langer, S. L., Abrams, J. R., Storer, B. E., & Martin, P. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.674 · Cited by 260
PARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure
Bai, P., Canto, C., Brunyánszki, A., Huber, A., Szántó, M., Cen, Y., Yamamoto, H., Houten, S. M., Kiss, B., Oudart, H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.013 · Cited by 251
Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.
Doroshow, J. H., Locker, G. Y., Ifrim, I., & Myers, C. E. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110328 · Cited by 245
Kerkela, R., Woulfe, K. C., Durand, J., Vagnozzi, R., Kramer, D., Chu, T. F., Beahm, C., Chen, M. H., & Force, T. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00090.x · Cited by 242
Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes
Grazette, L. P., Boecker, W., Matsui, T., Semigran, M., Force, T. L., Hajjar, R. J., & Rosenzweig, A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.066 · Cited by 241
Huillard, O., Mir, O., Peyromaure, M., Tlemsani, C., Giroux, J., Boudou-Rouquette, P., Ropert, S., Delongchamps, N. B., Zerbib, M., & Goldwasser, F. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.58 · Cited by 227
Lebrecht, D., Setzer, B., Ketelsen, U.-P., Haberstroh, J., & Walker, U. A. (2003) · Circulation · doi:10.1161/01.cir.0000093196.59829.df · Cited by 219
Cahill, C. M., Tzivion, G., Nasrin, N., Ogg, S., Dore, J., Ruvkun, G., & Alexander-Bridges, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010042200 · Cited by 219
Trastuzumab-containing regimens for metastatic breast cancer
Balduzzi, S., Mantarro, S., Guarneri, V., Tagliabue, L., Pistotti, V., Moja, L., & D'Amico, R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006242.pub2 · Cited by 218
Gruber, H. E., Hoffer, M. E., McAllister, D. R., Laikind, P. K., Lane, T. A., Schmid-Schoenbein, G. W., & Engler, R. L. (1989) · Circulation · doi:10.1161/01.cir.80.5.1400 · Cited by 201
Ying, W., Garnier, P., & Swanson, R. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01483-9 · Cited by 201
Wang, S.-C., & Hung, M.-C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2813 · Cited by 190
Chintalgattu, V., Ai, D., Langley, R. R., Zhang, J., Bankson, J. A., Shih, T. L., Reddy, A. K., Coombes, K. R., Daher, I. N., Pati, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39434 · Cited by 188
Zhang, P., Hu, X., Xu, X., Fassett, J., Zhu, G., Viollet, B., Xu, W., Wiczer, B., Bernlohr, D. A., Bache, R. J., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114702 · Cited by 187
Gordon, L. I., Burke, M. A., Singh, A. T. K., Prachand, S., Lieberman, E. D., Sun, L., Naik, T. J., Prasad, S. V. N., & Ardehali, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804570200 · Cited by 185
Doxorubicin targets multiple players: A new view of an old problem
Cappetta, D., Rossi, F., Piegari, E., Quaini, F., Berrino, L., Urbanek, K., & De Angelis, A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.016 · Cited by 183
Self-citationTrastuzumab-induced cardiac dysfunction: A 'dual-hit'.
Zeglinski, M. R., Lüdke, A., Jassal, D. S., & Singal, P. K. (2011) · Europe PMC (PubMed Central) · Cited by 181
Kluza, J., Marchetti, P., Gallego, M.-A., Lancel, S., Fournier, C., Loyens, A., Beauvillain, J.-C., & Bailly, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207936 · Cited by 179
Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise
Coven, D. L., Hu, X., Cong, L., Bergeron, R., Shulman, G. I., Hardie, D. G., & Young, L. H. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00171.2003 · Cited by 174
Mitochondria: gatekeepers of response to chemotherapy
Sarosiek, K. A., Ni Chonghaile, T., & Letai, A. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.08.003 · Cited by 171
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions
Supinski, G. S., & Callahan, L. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01138.2006 · Cited by 166
Adverse Effects of Doxorubicin and Its Metabolic Product on Cardiac RyR2 and SERCA2A
Hanna, A. D., Lam, A., Tham, S., Dulhunty, A. F., & Beard, N. A. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093849 · Cited by 163
Min, K., Kwon, O., Smuder, A. J., Wiggs, M. P., Sollanek, K. J., Christou, D. D., Yoo, J., Hwang, M., Szeto, H. H., Kavazis, A. N., et al. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.286518 · Cited by 162
Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes
Gilliam, L. A. A., Moylan, J. S., Patterson, E. W., Smith, J. D., Wilson, A. S., Rabbani, Z., & Reid, M. B. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00217.2011 · Cited by 161
Ascensão, A., Ferreira, R., & Magalhães, J. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.076 · Cited by 161
Ascensão, A., Magalhães, J., Soares, J. M. C., Ferreira, R., Neuparth, M. J., Marques, F., Oliveira, P. J., & Duarte, J. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01249.2004 · Cited by 160
Serrano, J., Palmeira, C. M., Kuehl, D. W., & Wallace, K. B. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00011-0 · Cited by 159
Ness, K. K., Baker, K. S., Dengel, D. R., Youngren, N. M., Sibley, S. D., Mertens, A. C., & Gurney, J. G. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.21091 · Cited by 158
Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase
Rasmussen, B. B., & Winder, W. W. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.4.1104 · Cited by 158
Cappetta, D., Esposito, G., Piegari, E., Russo, R., Ciuffreda, L. P., Rivellino, A., Berrino, L., Rossi, F., Angelis, A. D., & Urbanek, K. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.12.008 · Cited by 153
Self-citationYen, H., Oberley, T. D., Gairola, C. G., Szweda, L. I., & Clair, D. K. S. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1011 · Cited by 151
Marcillat, O., Zhang, Y., & Davies, K. J. A. (1989) · Biochemical Journal · doi:10.1042/bj2590181 · Cited by 149
Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle
Smuder, A. J., Kavazis, A. N., Min, K., & Powers, S. K. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00677.2010 · Cited by 141
Peng, X. (2005) · Molecular Interventions · doi:10.1124/mi.5.3.6 · Cited by 131
Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism
Ding, Y., Liu, Z., Desai, S., Zhao, Y., Liu, H., Pannell, L. K., Yi, H. L., Wright, E., Owen, L. B., Dean-Colomb, W. M., et al. (2012) · Nature Communications · doi:10.1038/ncomms2236 · Cited by 130
Gilliam, L. A. A., Fisher‐Wellman, K. H., Lin, C., Maples, J. M., Cathey, B. L., & Neufer, P. D. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.191 · Cited by 127
Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes
Sarvazyan, N. A. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.5.h2079 · Cited by 127
Hasinoff, B. B., Patel, D., & O’Hara, K. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050104 · Cited by 126
Direct effects of doxorubicin on skeletal muscle contribute to fatigue
van Norren, K., van Helvoort, A., Argilés, J. M. A., van Tuijl, S., Arts, K., Gorselink, M., Laviano, A., Kegler, D., Haagsman, H. P., & van der Beek, E. M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604858 · Cited by 124
Spector, N. L., Yarden, Y., Smith, B. L., Lyass, L., Trusk, P. B., Pry, K. J., Hill, J. E., Xia, W., Seger, R., & Bacus, S. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701286104 · Cited by 122
Herman, E., Ferrans, V. J., Myers, C. E., & Vleet, J. F. V. (1985) · PubMed · Cited by 120
Gilliam, L. A. A., Ferreira, L. F., Bruton, J. D., Moylan, J. S., Westerblad, H., Clair, D. K. S., & Reid, M. B. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00776.2009 · Cited by 116
Zorzato, F., Salviati, G., Facchinetti, T., & Pompeo Volpe, D. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39615-1 · Cited by 113
Cushen, S. J., Power, D. G., Teo, M. Y., MacEneaney, P. M., Maher, M. M., McDermott, R., O’Sullivan, K., & Ryan, A. M. (2014) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000061 · Cited by 109
Anthracycline cardiotoxicity in long-term survivors of childhood cancer
Scully, R. E., & Lipshultz, S. E. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0006-4 · Cited by 109
Functional Localization of Two Poly(ADP-Ribose)-Degrading Enzymes to the Mitochondrial Matrix
Niere, M., Kernstock, S., Koch‐Nolte, F., & Ziegler, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01766-07 · Cited by 109
A Deletion of Mitochondrial DNA in Murine Doxorubicin-Induced Cardiotoxicity
Adachi, K., Fujiura, Y., Mayumi, F., Nozuhara, A., Sugiu, Y., Sakanashi, T., Hidaka, T., & Toshima, H. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2135 · Cited by 103
Mechanism of anthraquinone-induced calcium release from skeletal muscle sarcoplasmic reticulum.
Abramson, J. J., Buck, E. D., Salama, G., Casida, J. E., & Pessah, I. N. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37347-2 · Cited by 103
Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy
Gilliam, L. A. A., Moylan, J. S., Callahan, L. A., Sumandea, M. P., & Reid, M. B. (2010) · Muscle & Nerve · doi:10.1002/mus.21809 · Cited by 102
Mantarro, S., Rossi, M., Bonifazi, M., D’Amico, R., Blandizzi, C., Vecchia, C. L., Negri, E., & Moja, L. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1362-x · Cited by 101
Effects of ranolazine in a model of doxorubicin‐induced left ventricle diastolic dysfunction
Cappetta, D., Esposito, G., Coppini, R., Piegari, E., Russo, R., Ciuffreda, L. P., Rivellino, A., Santini, L., Rafaniello, C., Scavone, C., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13791 · Cited by 101
Self-citationMitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?
Sorensen, J. C., Cheregi, B. D., Timpani, C. A., Nurgali, K., Hayes, A., & Rybalka, E. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3045-3 · Cited by 100
Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes
Yamamoto, Y., Hoshino, Y., Ito, T., Nariai, T., Mohri, T., Obana, M., Hayata, N., Uozumi, Y., Maeda, M., Fujio, Y., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn076 · Cited by 99
Molinari, F., Pin, F., Gorini, S., Chiandotto, S., Pontecorvo, L., Penna, F., Rizzuto, E., Pisu, S., Musarò, A., Costelli, P., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12226 · Cited by 97
Self-citationXiong, Y., Liu, X., Lee, C.-P., Chua, B. H. L., & Ho, Y.-S. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.02.024 · Cited by 96
Mitochondrial dysfunction mediated cisplatin induced toxicity: Modulatory role of curcumin
Waseem, M., & Parvez, S. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.11.055 · Cited by 96
Physical function and fitness in long-term survivors of childhood leukaemia
van Brussel, M., Takken, T., van der Net, J. J., Engelbert, R., Bierings, M., Schoenmakers, M. A. G. C., & Helders, P. J. M. (2006) · Developmental Neurorehabilitation · doi:10.1080/13638490500523150 · Cited by 96
Hasinoff, B. B. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.12.032 · Cited by 95
Ranolazine Protects from Doxorubicin-Induced Oxidative Stress and Cardiac Dysfunction
Tocchetti, C. G., Carpi, A., Coppola, C., Quintavalle, C., Rea, D., Campesan, M., Arcari, A., Piscopo, G., Cipresso, C., Monti, M. G., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.50 · Cited by 94
Increased Plasma Endothelin-1 and Cardiac Nitric Oxide during Doxorubicin-Induced Cardiomyopathy
Sayed‐Ahmed, M. M., Khattab, M. M., Gad, M. Z., & Osman, A. M. (2001) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2001.d01-148.x · Cited by 91
Järvelä, L. S., Kemppainen, J., Niinikoski, H., Hannukainen, J. C., Lähteenmäki, P. M., Kapanen, J., Arola, M. O., & Heinonen, O. J. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24049 · Cited by 91
Emerging role of neuregulin as a modulator of muscle metabolism
Gumà, A., Martínez-Redondo, V., López‐Soldado, I., Cantó, C., & Antonio Zorzano, A. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00541.2009 · Cited by 87
Montaigne, D., Hurt, C. N., & Nevière, R. (2012) · Biochemistry Research International · doi:10.1155/2012/951539 · Cited by 85
Angelis, A. D., Piegari, E., Cappetta, D., Russo, R., Esposito, G., Ciuffreda, L. P., Ferraiolo, F. A. V., Frati, C., Fagnoni, F. F., Berrino, L., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.438 · Cited by 82
Self-citationAutophagy plays an important role in Sunitinib-mediated cell death in H9c2 cardiac muscle cells
Zhao, Y., Xue, T., Yang, X., Zhu, H., Ding, X., Lou, L., Lu, W. P., Yang, B., & He, Q. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.07.007 · Cited by 80
Rasmussen, B. B., Hancock, C. R., & Winder, W. W. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.5.1629 · Cited by 78
Early changes in myocardial antioxidant enzymes in rats treated with adriamycin
Li, T., Danelisen, I., & Singal, P. K. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1014862912783 · Cited by 78
Exercise issues in older cancer survivors
Courneya, K. S. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.05.001 · Cited by 74
Anthracyclines and Mitochondria
Mordente, A., Meucci, E., Silvestrini, A., Martorana, G. E., & Giardina, B. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_18 · Cited by 74
Barreto, M. S. O. (2013) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000184 · Cited by 73
Argilés, J. M. A., López-Soriano, F. J., & Busquets, S. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000164 · Cited by 70
Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine
Ferraro, E., Pin, F., Gorini, S., Pontecorvo, L., Ferri, A., Mollace, V., Costelli, P., & Rosano, G. M. C. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12097 · Cited by 67
Self-citationGharanei, M., Hussain, A., Janneh, O., & Maddock, H. L. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.12.003 · Cited by 66
Scheede‐Bergdahl, C., & Jagoe, R. T. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00049 · Cited by 65
Gilliam, L. A. A., Lark, D. S., Reese, L., Torres, M. J., RYAN, T. E., Lin, C., Cathey, B. L., & Neufer, P. D. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00540.2015 · Cited by 61
Riccio, G., Coppola, C., Piscopo, G., Capasso, I., Maurea, C., Esposito, E., Lorenzo, C. D., & Maurea, N. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1125056 · Cited by 59
Trastuzumab versus lapatinib: The cardiac side of the story
Azim, H. A., Azim, H. A., & Escudier, B. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.06.007 · Cited by 55
Salvatorelli, E., Menna, P., Paz, O. G., Chello, M., Covino, E., Singer, J. W., & Minotti, G. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.200568 · Cited by 54
Ferraro, E., Giammarioli, A. M., Caldarola, S., Lista, P., Feraco, A., Tinari, A., Salvatore, A. M., Malorni, W., Berghella, L., & Rosano, G. M. C. (2013) · FEBS Journal · doi:10.1111/febs.12484 · Cited by 53
Self-citationProtection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4
Mohamed, H. E., Asker, M. E.-S., Ali, S. I., & Abd-Elfattah, T. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023565 · Cited by 49
Maurea, N., Coppola, C., Ragone, G., Frasci, G., Bonelli, A., Romano, C., & Iaffaioli, R. V. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328336b4c1 · Cited by 49
Pretto, F., Ghilardi, C., Moschetta, M., Bassi, A. L., Rovida, A., Scarlato, V., Talamini, L., Fiordaliso, F., Bisighini, C., Damia, G. L. M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2812 · Cited by 48
Impaired dynamics and function of mitochondria caused by mtDNA toxicity leads to heart failure
Lauritzen, K. H., Kleppa, L., Aronsen, J. M., Eide, L., Carlsen, H., Haugen, Ø. P., Sjaastad, I., Klungland, A., Rasmussen, L. J., Attramadal, H., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00253.2014 · Cited by 48
Albini, A., Cesana, E., Donatelli, F., Cammarota, R., Bucci, E., Baravelli, M., Anza', C., & Noonan, D. (2011) · Future Cardiology · doi:10.2217/fca.11.54 · Cited by 47
Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study
Bonifazi, M., Franchi, M., Rossi, M., Moja, L., Zambelli, A., Zambon, A., Corrao, G., Vecchia, C. L., Zocchetti, C., & Negri, E. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0065 · Cited by 45
Angelis, A. D., Cappetta, D., Piegari, E., Rinaldi, B., Ciuffreda, L. P., Esposito, G., Ferraiolo, F. A. V., Rivellino, A., Russo, R., Donniacuo, M., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.168 · Cited by 43
Self-citationAnimal models of cardiac cachexia
Molinari, F., Malara, N., Mollace, V., Rosano, G. M. C., & Ferraro, E. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.05.071 · Cited by 34
Self-citationSalvatorelli, E., Menna, P., Paz, O. G., Surapaneni, S., Aukerman, S. L., Chello, M., Covino, E., Sung, V., & Minotti, G. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190264 · Cited by 33
Heart Failure Associated with Sunitinib: Lessons Learned from Animal Models
Greineder, C. F., Kohnstamm, S., & Ky, B. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0225-8 · Cited by 30
The DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damage
Zio, D. D., Bordi, M., Tino, E., Lanzuolo, C., Ferraro, E., Mora, E. M., Ciccosanti, F., Fimia, G. M., Orlando, V., & Cecconi, F. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.125 · Cited by 28
Self-citationTalvensaari, K. K., Jämsén, A., Vanharanta, H. V., & Lanning, M. (1995) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(95)81033-1 · Cited by 27
Caspase-3 dependent cleavage and activation of skeletal muscle phosphorylase b kinase
Hilder, T. L., Carlson, G. M., Haystead, T., Krebs, E. G., & Graves, L. M. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-2411-y · Cited by 27
Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Prezioso, L., Tanzi, S., Galaverna, F., Frati, C., Testa, B., Savi, M., Graiani, G., Lagrasta, C. A. M., Cavalli, S., Galati, S., et al. (2010) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152510790796165 · Cited by 25
Recent insights into cardiac hypertrophy and left ventricular remodeling
Kerkelä, R., & Force, T. L. (2006) · Current Heart Failure Reports · doi:10.1007/s11897-006-0026-6 · Cited by 22
Sun, Y., Lin, H., Zhu, Y., Ma, C., Ye, J., & Luo, J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10132 · Cited by 19
Yamada, K., Sugiyama, S., Kosaka, K., Hayakawa, M., & Ozawa, T. (1995) · Experimental Gerontology · doi:10.1016/0531-5565(95)00033-x · Cited by 14
mtDNA damage in the development of heart failure
Lombardi, A. A., & Elrod, J. W. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00475.2015 · Cited by 9
Apaf1-deficient cortical neurons exhibit defects in axonal outgrowth
Zio, D. D., Molinari, F., Rizza, S., Gatta, L., Ciotti, M. T., Salvatore, A. M., Mathiassen, S. G., Cwetsch, A. W., Filomeni, G., Rosano, G. M. C., et al. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1927-x · Cited by 8
Self-citationPretto, F., Ghilardi, C., Moschetta, M., Bassi, A. L., Rovida, A., Scarlato, V., Talamini, L., Fiordaliso, F., Bisighini, C., Damia, G. L. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9971 · Cited by 4
Cited by
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska-Kołat, Ż., Celik, I., & Kontek, R. (2023) · Cells · doi:10.3390/cells12040659 · Cited by 810
A comprehensive review on time-tested anticancer drug doxorubicin
Sritharan, S., & Sivalingam, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119527 · Cited by 487
RONS and Oxidative Stress: An Overview of Basic Concepts
Aranda-Rivera, A. K., Cruz-Gregorio, A., Arancibia-Hernández, Y. L., Hernández-Cruz, E. Y., & Pedraza-Chaverri, J. (2022) · Oxygen · doi:10.3390/oxygen2040030 · Cited by 384
Telomerase therapy attenuates cardiotoxic effects of doxorubicin
Chatterjee, S., Hofer, T., Costa, A., Lu, D., Batkai, S., Gupta, S. K., Bolesani, E., Zweigerdt, R., Megias, D., Streckfuss-Bömeke, K., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.035 · Cited by 63
Kirsch, V., Ramge, J.-M., Schoppa, A., Ignatius, A., & Riegger, J. (2022) · Cells · doi:10.3390/cells11071106 · Cited by 47
Metadata
- Authors
- Gorini, S., De Angelis, A., Berrino, L., Malara, N., Rosano, G., & Ferraro, E.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 2018
- Issue
- 1
- Pages
- 7582730-7582730
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2791893068
- Cited by
- 325
- References
- 147
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.